![Civil society position on the proposal of the European Commission for the introduction of a Supplementary Protection Certificate (SPC) manufacturing waiver | European Alliance for Responsible R&D and Affordable Medicines Civil society position on the proposal of the European Commission for the introduction of a Supplementary Protection Certificate (SPC) manufacturing waiver | European Alliance for Responsible R&D and Affordable Medicines](https://medicinesalliance.eu/wp-content/uploads/2016/09/medications-342462_1920-1080x675.jpg)
Civil society position on the proposal of the European Commission for the introduction of a Supplementary Protection Certificate (SPC) manufacturing waiver | European Alliance for Responsible R&D and Affordable Medicines
![Medicines for Europe Position Paper on Unitary SPC-Unified Mechanism for SPC granting – March 2021 | Medicines for Europe Medicines for Europe Position Paper on Unitary SPC-Unified Mechanism for SPC granting – March 2021 | Medicines for Europe](https://www.medicinesforeurope.com/wp-content/uploads/2021/02/Medicines-for-Europe-Position-Paper-on-Unitary-SPC-Unified-Mechanism-for-SPC-granting-March-2021-pdf.jpg)
Medicines for Europe Position Paper on Unitary SPC-Unified Mechanism for SPC granting – March 2021 | Medicines for Europe
![PDF) Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib PDF) Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib](https://i1.rgstatic.net/publication/338573339_Supplementary_protection_certificates_and_their_impact_on_access_to_medicines_in_Europe_case_studies_of_sofosbuvir_trastuzumab_and_imatinib/links/5e1db2df458515d2b46acd14/largepreview.png)
PDF) Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinib
![Medicines for Europe on Twitter: "Risk that @EUCouncil will “Neuter” SPC Manufacturing Waiver and give foreign (Non-EU) manufacturers strong advantage over EU-based manufacturers. #SPCWaiver https://t.co/grGOC1RlIE https://t.co/pWiIuc2mMG" / Twitter Medicines for Europe on Twitter: "Risk that @EUCouncil will “Neuter” SPC Manufacturing Waiver and give foreign (Non-EU) manufacturers strong advantage over EU-based manufacturers. #SPCWaiver https://t.co/grGOC1RlIE https://t.co/pWiIuc2mMG" / Twitter](https://pbs.twimg.com/media/DpS7IBbV4AACvIQ.jpg)
Medicines for Europe on Twitter: "Risk that @EUCouncil will “Neuter” SPC Manufacturing Waiver and give foreign (Non-EU) manufacturers strong advantage over EU-based manufacturers. #SPCWaiver https://t.co/grGOC1RlIE https://t.co/pWiIuc2mMG" / Twitter
![Medicines for Europe Position Paper on Unitary SPC-Unified Mechanism for SPC granting – March 2021 | Medicines for Europe Medicines for Europe Position Paper on Unitary SPC-Unified Mechanism for SPC granting – March 2021 | Medicines for Europe](https://www.medicinesforeurope.com/wp-content/uploads/2021/02/Medicines-for-Europe-Position-Paper-on-Unitary-SPC-Unified-Mechanism-for-SPC-granting-March-2021-pdf-212x300.jpg)
Medicines for Europe Position Paper on Unitary SPC-Unified Mechanism for SPC granting – March 2021 | Medicines for Europe
![Home delivery program from SPC to be launched - Gold FM News - Srilanka's Number One News Portal, Most visited website in Sri Lanka Home delivery program from SPC to be launched - Gold FM News - Srilanka's Number One News Portal, Most visited website in Sri Lanka](https://cdn.hirunews.lk/Data/News_Images/202012/1607424373_3095332_hirunews.jpg)
Home delivery program from SPC to be launched - Gold FM News - Srilanka's Number One News Portal, Most visited website in Sri Lanka
![Supplementary protection certificate (SPC) and new therapeutic applications: Where do we stand? | Plasseraud IP Supplementary protection certificate (SPC) and new therapeutic applications: Where do we stand? | Plasseraud IP](https://www.plass.com/sites/default/files/styles/image_950x395_/public/field/article/Visu_article_Medicine_nsl_internet_0.jpg?itok=P5xFlOCo)